MarginsXMarginsX
Home › Data Desk › Context Therapeutics Inc.'s 10-Q carries going-concern doubt

MarginsX Data Desk · Going-concern doubt · Early-stage clinical trials · Licensing and milestone payments · Oncology

Context Therapeutics Inc.'s 10-Q carries going-concern doubt

In its 10-Q, filed Nov 10, 2026, Context Therapeutics Inc. (CNTX) disclosed substantial doubt that it can carry on as a going concern. (SEC EDGAR, 10-Q, Nov 10, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 10, 2026.

Line chart of Context Therapeutics Inc. (CNTX) daily closes from Jul 6, 2026 to Nov 10, 2026, with the going-concern filing on Nov 10, 2026 marked.

The filing reads: “As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.” (SEC EDGAR, 10-Q, Nov 10, 2026)

Why we call it new

Its previous periodic report, the 10-Q filed Aug 5, 2026, did not match EDGAR full-text search for going-concern language when we last ran it on Nov 14, 2026. (SEC EDGAR, 10-Q, Aug 5, 2026)

Cash and dilution

It reported cash of $34.4M as of Sep 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

At its recent quarterly burn rate that cash lasts about 12.2 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

The stock

The Nasdaq screener puts its market value at $16.6M. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/CNTX)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameContext Therapeutics Inc.Source2026-11-13
Form10-QSource2026-11-10
FiledNov 10, 2026Source2026-11-10
WhoContext Therapeutics Inc. (CNTX)Source2026-11-13
SymbolCNTXSource2026-11-13
SentenceAs a result, the Company has concluded that there is substanSource2026-11-10
Prev form10-QSource2026-08-05
Prev filedAug 5, 2026Source2026-08-05
Fts checkedNov 14, 2026Source2026-11-14
Cash34,410,919 USDSource2026-09-30
Cash dateSep 30, 2026Source2026-09-30
Runway12.2 monthsSource2026-09-30
Cap16,611,755 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS